Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Unveiling the hidden variation: the role of RNA editing in autistic brain
FY 2013-14
Summary
Autism spectrum disorder (ASD) is a prevalent and highly heritable disease, now affecting 1 in 50 children according to a recent estimate in 2013 from CDC in US. Much of our knowledge about this disease has been learned from identifying genes with ASD-associated mutations. Although now it is largely agreed that this disease might arise from defects in synaptic transmission in brain, its molecular etiology and underlying genetic pathways stills remains elusive. Despite its strong genetic component, recent twin study further revealed that a significant portion of this disease is also contributed from non-genetic factors, whose biological basis, however, is even poorly explored. In this study, we hypothesize that one non-genetic and epigenetic mechanism, RNA editing, may be significantly implicated in autism, which makes discrete modifications of RNA nucleotides from their genome-encoded sequences and which preferentially target synaptic genes. To test this, we will profile RNA editing events across 4 brain regions most relevant to this disease among patients with autism. By comparing with their respectively matched control subjects, we will identify genes mis-edited in the patients and assess their functional consequences for autistic behaviors. Our pilot study has indeed identified several strong candidate genes, and these abnormalities are solely at the RNA level, and thus cannot be detected in any previous DNA-based screens. Overall, the proposed study will be the first revelation of the RNA editome in autistic brain, will unveil a new mechanism and will nurture future therapeutic development for this disease.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
296919
Name
Li Jingjing
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Unveiling the hidden variation: the role of RNA editing in autistic brain
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Autism Spectrum Disorder; Genomics; Rna Editing
Abstract
Autism spectrum disorder (ASD) is a prevalent and highly heritable disease, now affecting 1 in 50 children according to a recent estimate in 2013 from CDC in US. Much of our knowledge about this disease has been learned from identifying genes with ASD-associated mutations. Although now it is largely agreed that this disease might arise from defects in synaptic transmission in brain, its molecular etiology and underlying genetic pathways stills remains elusive. Despite its strong genetic component, recent twin study further revealed that a significant portion of this disease is also contributed from non-genetic factors, whose biological basis, however, is even poorly explored. In this study, we hypothesize that one non-genetic and epigenetic mechanism, RNA editing, may be significantly implicated in autism, which makes discrete modifications of RNA nucleotides from their genome-encoded sequences and which preferentially target synaptic genes. To test this, we will profile RNA editing events across 4 brain regions most relevant to this disease among patients with autism. By comparing with their respectively matched control subjects, we will identify genes mis-edited in the patients and assess their functional consequences for autistic behaviors. Our pilot study has indeed identified several strong candidate genes, and these abnormalities are solely at the RNA level, and thus cannot be detected in any previous DNA-based screens. Overall, the proposed study will be the first revelation of the RNA editome in autistic brain, will unveil a new mechanism and will nurture future therapeutic development for this disease.
Competitiondate
201310
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Li, Jingjing
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~